产品名称 | NebuSelect™ Recombinant Human CXCL4, hFc-tag |
---|---|
目录号 | NBL-241034 |
别名 | CXCL4; PF-4; Oncostatin-A; CXCL4; SCYB4; Iroplact; MGC138298 |
外观 | see COA |
分子量 | Glu32-Ser101 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P02776 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-241034-100ug | 100ug | Inquire | Inquire | |
NBL-241034-1mg | 1mg | Inquire | Inquire | |
NBL-241034-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human CXCL4, hFc-tag
Catalog#:
NBL-241034
Description:
NebuSelect™ Recombinant Human CXCL4, hFc-tag(Cat#NBL-241034) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Glu32-Ser101.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 34.5 kDa. Due to glycosylation, the protein migrates to 40-50 kDa based on Bis-Tris PAGE result.
Target Name:
CXCL4; PF-4; Oncostatin-A; CXCL4; SCYB4; Iroplact; MGC138298
Target Information:
Chemokines regulate leukocyte migration during physiological and pathological conditions. It is currently accepted that these chemotactic cytokines are also important in the development and progression of cancer. CXCL4 and its non-allelic variant CXCL4L1 are two platelet-associated chemokines that have been attributed anti-tumoral activity as a result of their angiostatic potential and the chemotactic activity for anti-tumoral leukocytes.
Amino Acid Sequence:
Glu32-Ser101
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.